Regenerative Medical Technology (RMTG) Current Leases (2022 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Current Leases of $165567.0 for Q1 2026, up 157.99% year-over-year from $64176.0 in Q1 2025, and down 24.73% quarter-over-quarter from $219973.0 in Q4 2025.
Regenerative Medical Technology (RMTG) Current Leases (2022 - 2026) Analysis & Trends
Regenerative Medical Technology's Current Leases history runs 5 years deep, the most recent figure standing at $165567.0 for Q1 2026.
- In Q1 2026, Current Leases rose 157.99% year-over-year to $165567.0; the TTM figure through Mar 2026 stood at $165567.0 (up 157.99% YoY), while the FY2025 annual figure was $219973.0, up 246.2% from the prior year.
- Current Leases for Q1 2026 stood at $165567.0, down from $219973.0 in the prior quarter.
- The five-year high for Current Leases was $219973.0 in Q4 2025, with the low at $2714.0 in Q4 2023.
- The 5-year median for Current Leases is $63540.0 (2024), against an average of $69469.1.
- The sharpest annual moves came in 2023 and 2024: Current Leases tumbled 91.67% in 2023, then soared 2241.19% in 2024.
- Regenerative Medical Technology's Current Leases stood at $32568.0 in 2022, then sank by 91.67% to $2714.0 in 2023, then jumped by 2241.19% to $63540.0 in 2024, then surged by 246.2% to $219973.0 in 2025, then declined by 24.73% to $165567.0 in 2026.
- Business Quant data shows RMTG's Current Leases at $165567.0 in Q1 2026, $219973.0 in Q4 2025, and $186516.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Regenerative Medical Technology | 961,772.49 | -99,675.51 | 1.77 Mn | 165,567.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 165,567.00 |
| Dec 31, 2025 | 219,973.00 |
| Sep 30, 2025 | 186,516.00 |
| Jun 30, 2025 | 64,176.00 |
| Mar 31, 2025 | 64,176.00 |
| Dec 31, 2024 | 63,540.00 |
| Sep 30, 2024 | 76,092.00 |
| Jun 30, 2024 | 76,092.00 |
| Mar 31, 2024 | 76,092.00 |
| Dec 31, 2023 | 2,714.00 |
| Sep 30, 2023 | 10,753.00 |
| Jun 30, 2023 | 18,638.00 |
| Mar 31, 2023 | 26,374.00 |
| Dec 31, 2022 | 32,568.00 |
| Sep 30, 2022 | 32,568.00 |
| Jun 30, 2022 | 32,568.00 |
| Mar 31, 2022 | 32,568.00 |